PrimeVigilance, an Ergomed company headquartered in Guildford, on the 22nd of July 2019 was honored by the visit of HM The Lord-Lieutenant of Surrey, Michael More-Molyneux to present the prestigious 2019 Queen’s Award in the presence of the Mayor of Guildford and Councillor Richard Billington.
23 August 2019.
PrimeVigilance, an Ergomed company is pleased to announce and welcome the appointment of Dr. Olaolu Imasogie as Chief Medical Officer, with immediate effect.
22 August 2019.
As part of the Ergomed Group, PrimeVigilance is delighted to announce that Ergomed has been featured in the London Stock Exchange’s 1000 Companies to Inspire Britain 2019 report.
3 July 2019.
We are very pleased to share that Dr. Michael Forstner, Senior VP and Head of Pharmacoepidemiology & Risk Management, will give a lecture at the upcoming #DIA2019.
3 June 2019.
This session takes place on Thursday 13th June 2019, 10:00 EDT | 15:00 BST | 16:00 CEST
Following on from part 1 of this webinar series, our experts Senior Vice President and Head of Pharmacoepidemiology and Risk Management, Dr Michael Forstner, Senior Director Pharmacoepidemiology, Maartje Smulders, and Ergomed’s Head of RWE and Late Phase Division, Dr Alex Artyomenko will discuss real-world research designs, methodological challenges and solutions together with several real-world study case examples.
15 May 2019.
We are pleased to share the news that Maartje Smulders, PrimeVigilance Senior Director of Pharmacoepidemiology, was invited this May to speak and present at ESPID and ISPOR 2019 annual conferences
7 May 2019.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)